Bromide source for use in treating autism spectral disorder
US12036237B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 20, 2023 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Apr 20, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.